GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
1.090
-0.020 (-1.80%)
At close: Aug 25, 2025, 4:00 PM
1.082
-0.008 (-0.74%)
After-hours: Aug 25, 2025, 6:40 PM EDT
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $3.88 million as of August 25, 2025. Its market cap has decreased by -20.09% in one year.
Market Cap
3.88M
Enterprise Value
-1.28M
1-Year Change
-20.09%
Ranking
Category
Stock Price
$1.09
Market Cap Chart
Since October 18, 1983, GT Biopharma's market cap has decreased from $937.50M to $3.88M, a decrease of -99.59%. That is a compound annual growth rate of -12.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 3.95M | -42.05% |
| Dec 31, 2024 | 6.81M | -35.48% |
| Dec 29, 2023 | 10.56M | -63.37% |
| Dec 30, 2022 | 28.84M | -69.01% |
| Dec 31, 2021 | 93.05M | 159.67% |
| Dec 31, 2020 | 35.83M | 556.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |